Variant ID: 1-55529871-C-T

NM_174936.3(PCSK9):c.*614C>T

This variant was identified in 3 publications




Publications:


Association of a 3' untranslated region polymorphism in proprotein convertase subtilisin/kexin type 9 with HIV viral load and CD4+ levels in HIV/hepatitis C virus coinfected women.

Aids (London, England)
MH Kuniholm, H Liang, K Anastos, D Gustafson, S Kassaye, M Nowicki, BE Sha, EJ Pawlowski, SJ Gange, BE Aouizerat, T Pushkarsky, MI Bukrinsky, VR Prasad
Publication Date: 2017-11-28

Variant appearance in text: N/A
PMID: 29120899
View BVdb publication page



Association of the variants and haplotypes in the DOCK7, PCSK9 and GALNT2 genes and the risk of hyperlipidaemia.

Journal Of Cellular And Molecular Medicine
T Guo, RX Yin, WX Lin, W Wang, F Huang, SL Pan
Publication Date: 2016-02

Variant appearance in text: N/A
PMID: 26493351
View BVdb publication page



Impact of 3'UTR genetic variants in PCSK9 and LDLR genes on plasma lipid traits and response to atorvastatin in Brazilian subjects: a pilot study.

International Journal Of Clinical And Experimental Medicine
T Zambrano, MH Hirata, Á Cerda, EL Dorea, GA Pinto, MC Gusukuma, MC Bertolami, LA Salazar, RD Hirata
Publication Date: 2015

Variant appearance in text: rs17111557
PMID: 26131194
View BVdb publication page



Alternative transcript annotations:

Transcript cDNA Protein Consequence Exon Intron
ENST00000302118.5 c.*614C>T - 3_prime_UTR_variant 12/12 -
ENST00000490692.1 n.3239C>T - non_coding_transcript_exon_variant 8/8 -
NM_174936.4 c.*614C>T - 3_prime_UTR_variant 12/12 -
NR_110451.1 n.2300C>T - non_coding_transcript_exon_variant 10/10 -